The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Brigham and Women's Hospital
Study ID
NCT07315997
Status
Recruiting

Conditions

  • Atherosclerotic Cardiovascular Disease (ASCVD)
  • Rheumatoid Arthritis (RA

Eligibility Criteria

Sex
ALL
Age
35 Years - 79 Years
Healthy Volunteers
Not accepted

Interventions

  • high sensitivity cardiac troponin — DIAGNOSTIC_TEST
    Blood measurement of high sensitivity cardiac troponin

Study Details

Individuals with rheumatoid arthritis (RA) have up to 2x the risk of having a heart attack compared to someone without RA. The goal of this study is to identify biomarkers that can help us do a better job of identifying individuals at risk before they develop symptoms of heart disease and start preventative treatment earlier.

Key Dates

First listed
Jan 5, 2026
Start date
Sep 4, 2024
Status verified
Dec 2025
Primary completion
Mar 4, 2028
Completion
Mar 4, 2028

Study Design

Enrollment
120 participants (estimated)

Primary Outcome Measure

coronary artery calcium score [ Time Frame: Cross-sectional, at baseline ]

Locations (3)

FacilityCityStateZIPSite coordinators
Brigham and Women's Faulkner HospitalBostonMassachusetts02130
Nicole Yang, MD
6179837720
Abisayo Animashaun, MS
617-732-8169
Nicole Yang, MD (PRINCIPAL_INVESTIGATOR)
Brigham and Womens HospitalBostonMassachusetts02115
Katherine P Liao, MD, MPH
617-525-8819
Abisayo Animashaun, MS
617-732-8169
Katherine P Liao, MD, MPH (PRINCIPAL_INVESTIGATOR)
Massachusetts General Hospital: RheumatologyBostonMassachusetts02114
Sheila Arvikar, MD
6177267938
Abisayo Animashaun, MS
617-732-8169
Sheila Arvikar, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Boston, MA

Related Studies